GENE ONLINE|News &
Opinion
Blog

Asthma
Trials & Approvals AstraZenecaEosinophilic Asthma
China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma
2024-08-21
Editors' Picks Asthma
Asthma Medications: From Quick Relief to Long-Term Control
2024-03-11
M&A GSKGlaxoSmithKlineAsthmam&a
GSK Completed the Acquisition of Aiolos Bio, Enhancing the Respiratory Portfolio of Asthma
2024-02-16
Regulatory AstraZenecaAsthma
AstraZeneca’s severe asthma drug Tezspire has been granted market authorization in South Korea
2023-12-25
Innovation AsthmaSleep Deprivation
Have A Good Night’s Sleep To Cut Asthma Risk
2023-04-17
Trials & Approvals Asthma
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Trials & Approvals Clinical Trial
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Funding Pan-JAK Inhibitor
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Trials & Approvals Asthma
Amgen, AstraZeneca’s Tezepelumab Impresses in Phase 3 Asthma Trial
2020-11-11
Technology Apple
Can Your Smartwatch Help You Manage Asthma Better?
2020-09-19
COVID-19 Japan
Japan Trials Asthma Drug Alvesco to fight COVID-19
2020-03-29
R&D Asthma
Astra Zeneca to Resume Rivalry with Old Competitor Following Key Win for FASENRA®
2019-10-14
Trials & Approvals Asthma
Novartis Reports Trial Successes of its Asthma Drugs that Holds Potential Edge Over Longstanding Market Leader
2019-10-04
Trials & Approvals Autoimmune
Novartis’s Ligelizumab Progresses to Phase III Trial
2018-12-17
LATEST
Bio Japan 2024 and Medical Japan 2024 Unleashing Innovation in Biopharmaceuticals and Healthcare Technologies
2024-10-07
Starboard Value Takes $1 Billion Stake in Pfizer, Eyes Major Overhaul
2024-10-07
Generative AI Makes its Debut in Smart Healthcare with NVIDIA Experts at the Helm
2024-10-04
How TCELS is Moving Thailand’s Biotech Industries From Local to Global
2024-10-04
Lilly Invests $4.5B in Indiana Facility for In-House Clinical Manufacturing
2024-10-03
Can New GLP-1 Contenders Disrupt the Weight-Loss Giants, Lilly and Novo, in the Battle for Market Dominance?
2024-10-03
2024 Tang Prize Celebrates Revolutionary Biopharma Discoveries, a Nod to Game-Changing Diabetes and Obesity Treatments
2024-09-30
READ MORE
EVENT
2024-10-09
Medical Japan 2024 Tokyo
Tokyo, Japan
2024-10-10
BioJapan / Regenerative Medicine Japan / healthTECH JAPAN 2024
Tokyo, Japan
2024-10-15
BIO Investor Forum 2024
San Francisco, U.S.A.
2024-10-28
BioFuture 2024
New York, U.S.A.
2024-10-30
AusBiotech 2024
Melbourne, Australia
2024-11-04
BIO-Europe 2024
Stockholm, Sweden
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top